Adverse drug reactions caused by drug-drug interactions in elderly outpatients: a prospective cohort study

被引:77
作者
Obreli-Neto, Paulo Roque [1 ]
Nobili, Alessandro [2 ,3 ]
Baldoni, Andre de Oliveira [4 ]
Guidoni, Camilo Molino [4 ]
de Lyra Junior, Divaldo Pereira [5 ]
Pilger, Diogo [6 ]
Duzanski, Juliano [7 ]
Tettamanti, Mauro [2 ,3 ]
Cruciol-Souza, Joice Mara [8 ]
Gaeti, Walderez Penteado [1 ]
Nakamura Cuman, Roberto Kenji [1 ]
机构
[1] Univ Estadual Maringa, Dept Pharmacol & Therapeut, BR-87020290 Maringa, Parana, Brazil
[2] Ist Ric Farmacol Mario Negri, Lab Qual Assessment Geriatr Therapies & Serv, Milan, Italy
[3] Ist Ric Farmacol Mario Negri, Drug Informat Serv Elderly, Milan, Italy
[4] Univ Sao Paulo, Dept Pharmaceut Sci, BR-14049 Ribeirao Preto, SP, Brazil
[5] Univ Fed Sergipe, Lab Teaching & Res Social Pharm, Sao Cristovao, SE, Brazil
[6] Univ Fed Bahia, Dept Med, Salvador, BA, Brazil
[7] Fac Integradas Ourinhos, Dept Pharm, Ourinhos, SP, Brazil
[8] Univ Estadual Londrina, Dept Pharmaceut Sci, Londrina, PR, Brazil
关键词
Drug interactions; Drug toxicity; Age; Outpatients; Cohort studies; Pharmacovigilance; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; IN-HOSPITAL INPATIENTS; DIGITALIS GLYCOSIDES; MANIFESTATIONS; HYPERKALEMIA; PREVALENCE; MECHANISMS; THERAPY; EVENTS; RISK;
D O I
10.1007/s00228-012-1309-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Although the prevalence of drug-drug interactions (DDIs) in elderly outpatients is high, many potential DDIs do not have any actual clinical effect, and data on the occurrence of DDI-related adverse drug reactions (ADRs) in elderly outpatients are scarce. This study aimed to determine the incidence and characteristics of DDI-related ADRs among elderly outpatients as well as the factors associated with these reactions. A prospective cohort study was conducted between 1 November 2010 and 31 November 2011 in the primary public health system of the Ourinhos micro-region, Brazil. Patients aged a parts per thousand yen60 years with at least one potential DDI were eligible for inclusion. Causality, severity, and preventability of the DDI-related ADRs were assessed independently by four clinicians using validated methods; data were analysed using descriptive analysis and multiple logistic regression. A total of 433 patients completed the study. The incidence of DDI-related ADRs was 6 % (n = 30). Warfarin was the most commonly involved drug (37 % cases), followed by acetylsalicylic acid (17 %), digoxin (17 %), and spironolactone (17 %). Gastrointestinal bleeding occurred in 37 % of the DDI-related ADR cases, followed by hyperkalemia (17 %) and myopathy (13 %). The multiple logistic regression showed that age a parts per thousand yen80 years [odds ratio (OR) 4.4; 95 % confidence interval (CI) 3.0-6.1, p < 0.01], a Charlson comorbidity index a parts per thousand yen4 (OR 1.3; 95 % CI 1.1-1.8, p < 0.01), consumption of five or more drugs (OR 2.7; 95 % CI 1.9-3.1, p < 0.01), and the use of warfarin (OR 1.7; 95 % CI1.1-1.9, p < 0.01) were associated with the occurrence of DDI-related ADRs. With regard to severity, approximately 37 % of the DDI-related ADRs detected in our cohort necessitated hospital admission. All DDI-related ADRs could have been avoided (87 % were ameliorable and 13 % were preventable). The incidence of ADRs not related to DDIs was 10 % (n = 44). The incidence of DDI-related ADRs in elderly outpatients is high; most events presented important clinical consequences and were preventable or ameliorable.
引用
收藏
页码:1667 / 1676
页数:10
相关论文
共 46 条
  • [1] Abarca Jacob, 2004, J Am Pharm Assoc (2003), V44, P136, DOI 10.1331/154434504773062582
  • [2] [Anonymous], US EP STUD ELD
  • [3] Drug-drug interactions in the elderly
    Björkman, IK
    Fastbom, J
    Schmidt, IK
    Bernsten, CB
    [J]. ANNALS OF PHARMACOTHERAPY, 2002, 36 (11) : 1675 - 1681
  • [4] Predicting the Clinical Relevance of Drug Interactions From Pre-Approval Studies
    Caccia, Silvio
    Garattini, Silvio
    Pasina, Luca
    Nobili, Alessandro
    [J]. DRUG SAFETY, 2009, 32 (11) : 1017 - 1039
  • [5] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [6] Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy Implications for Risk Assessment, Prevention and Treatment
    Chatzizisis, Yiannis S.
    Koskinas, Konstantinos C.
    Misirli, Gesthimani
    Vaklavas, Christos
    Hatzitolios, Apostolos
    Giannoglou, George D.
    [J]. DRUG SAFETY, 2010, 33 (03) : 171 - 187
  • [7] Cruciol-Souza JM, 2006, J PHARM PHARM SCI, V9, P427
  • [8] Cusack Barry J, 2004, Am J Geriatr Pharmacother, V2, P274, DOI 10.1016/j.amjopharm.2004.12.005
  • [9] Adverse drug reactions in hospital in-patients: a pilot study
    Davies, E. C.
    Green, C. F.
    Mottram, D. R.
    Pirmohamed, M.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2006, 31 (04) : 335 - 341
  • [10] Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
    Davies, Emma C.
    Green, Christopher F.
    Taylor, Stephen
    Williamson, Paula R.
    Mottram, David R.
    Pirmohamed, Munir
    [J]. PLOS ONE, 2009, 4 (02):